论文部分内容阅读
摘要目的评估~(18)F-FDG PET代谢活性与胶质母细胞瘤治疗后在MRI上疑病情进展的病人,其生存情况之间的相关性。材料与方法本研究共纳入于2006—2015年期间接受诊疗的、符合入组标准的胶质母细胞瘤病人56例。入组标准包括:(1)经手术切除肿瘤并接受术后同步放化疗(放疗+替莫唑胺);(2)治疗后随访MRI确定病情进展并接受FDG PET/CT检查。研究者对入组病人残存病灶区(由MRI确定)的
Abstract Objective To evaluate the correlation between the metabolic activity of ~ (18) F-FDG PET and the survival of patients suspected of developing disease on MRI after treatment of glioblastoma. Materials and Methods The study included 56 patients with glioblastoma who met the criteria of inclusion during 2006-2015. Inclusion criteria included: (1) surgical resection of the tumor and concurrent chemoradiation (radiotherapy + temozolomide); and (2) follow-up of MRI to determine disease progression and FDG PET / CT after treatment. Researchers on the remaining patients into the lesion area (MRI)